Tau protein, beta-amyloid1-42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia

The results of the present study support the role of clusterin in PD pathogenesis. The decreasing CSF beta-amyloid1-42 levels in the order PDD, DLB and AD may relate to the increasing presence of AD pathology in these disorders.